The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: A systematic review

European Urology

Volumn 60, Issue 1, 2011, Pages 81-93

  Lammers, Rianne J M ^a   Witjes, J Alfred ^a   Inman, Brant A ^b   Leibovitch, Ilan ^c   Laufer, Menachem ^d   Nativ, Ofer ^e   Colombo, Renzo ^f  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MEIR MEDICAL CENTER   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e BNAI ZION MEDICAL CENTER   (Israel)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Adverse events; Chemohyperthermia; Device assisted therapy; Hyperthermia; Intravesical chemotherapy; Mitomycin C; Non muscle invasive bladder cancer; Progression; Recurrence; Thermochemotherapy

Indexed keywords

APAZIQUONE; EPIRUBICIN; GEMCITABINE; MITOMYCIN; PEPLEOMYCIN;

BLADDER CANCER; BLADDER SPASM; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMOHYPERTHERMIA; COCHRANE LIBRARY; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; CYSTALGIA; CYSTITIS; CYSTOSTOMY; DRUG EFFICACY; DRUG ERUPTION; DYSURIA; EMBASE; FOLLOW UP; HEMATURIA; HUMAN; HYPEREMIA; HYPERTHERMIC THERAPY; IN VITRO STUDY; MEDLINE; NOCTURIA; NON MUSCLE INVASIVE BLADDER CANCER; PHOTODYNAMIC THERAPY; POSTERIOR WALL THERMAL REACTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; THERMAL INJURY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINARY URGENCY; URINE INCONTINENCE;

ADMINISTRATION, INTRAVESICAL; ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; MITOMYCIN; URINARY BLADDER NEOPLASMS;

EID: 79957947567     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.04.023     Document Type: Review

References (48)

1. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, and J. Palou-Redorta EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 54 2008 303 314
2. M.C. Hall, S.S. Chang, and G. Dalbagni Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update J Urol 178 2007 2314 2330 (Pubitemid 350080987)
3. R. Colombo, L.F. Da Pozzo, and A. Salonia Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma J Clin Oncol 21 2003 4270 4276 (Pubitemid 46621801)
4. A.G. Van der Heijden, G. Verhaegh, C.F. Jansen, J.A. Schalken, and J.A. Witjes Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study J Urol 173 2005 1375 1380 (Pubitemid 40380578)
5. R. Paroni, A. Salonia, and A. Lev Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma Br J Clin Pharmacol 52 2001 273 278 (Pubitemid 33796224)
6. J.P.T. Higgins, and S. Green Cochrane Handbook for Systematic Reviews of Interventions, v.5.0.2 2009 Wiley Hoboken, NJ
7. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 2010 336 341
8. B.C. Wallace, C.H. Schmid, J. Lau, and T.A. Trikalinos Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data BMC Med Res Methodol 9 2009 80
9. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
10. D.R. Yates, and M. Roupret Failure of bacille Calmette-Guerin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options BJU Int 106 2010 162 167
11. O. Nativ, J.A. Witjes, and K. Hendricksen Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin J Urol 182 2009 1313 1317
12. J.Y. Fang, and Z.R. Huang Intravesical drug delivery into the bladder to treat cancers Curr Drug Deliv 6 2009 227 237
13. M.C. Smaldone, B.A. Gayed, J.J. Tomaszewski, and J.R. Gingrich Strategies to enhance the efficacy of intravesical therapy for non-muscle invasive bladder cancer Minerva Urol Nefrol 61 2009 71 89
14. Halachmi S, Moskovitz B, Maffezzini M, et al. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder. Urol Oncol. In press. DOI:10.1016/j.urolonc.2009.02.012.
15. R. Colombo Combined treatment with local thermo-chemotherapy for non muscle invasive bladder cancer. The present role in the light of acquired data and preliminary cumulative clinical experiences Arch Ital Urol Androl 80 2008 149 156
16. J.A. Witjes, K. Hendricksen, O. Gofrit, O. Risi, and O. Nativ Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo working party World J Urol 27 2009 319 324
17. M.A. Brausi New strategies in the treatment of Ta-T1 transitional cell carcinoma (TCC) of the bladder Scientific World Journal 6 2006 2632 2637
18. J.A. Witjes Management of BCG failures in superficial bladder cancer: a review Eur Urol 49 2006 790 797
19. B. Moskovitz, G. Meyer, and A. Kravtzov Thermo-chemotherapy for intermediate or high-risk recurrent superficial bladder cancer patients Ann Oncol 16 2005 585 589 (Pubitemid 40613324)
20. A.G. van der Heijden, C.F.J. Jansen, G. Verhaegh, M.A. O'Donnell, J.A. Schalken, and J.A. Witjes The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines Eur Urol 46 2004 670 674 (Pubitemid 39345746)
21. F.N. Joudi, and M.A. O'Donnell Second-line intravesical therapy versus cystectomy for bacille Calmette-Guerin (BCG) failures Curr Opin Urol 14 2004 271 275 (Pubitemid 39141983)
22. A.G. Van der Heijden, L.A. Kiemeney, and O.N. Gofrit Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder Eur Urol 46 2004 65 72 (Pubitemid 38748512)
23. O.N. Gofrit, A. Shapiro, and D. Pode Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer Urology 63 2004 466 471
24. D.L. Lamm Intravesical therapy for superficial bladder cancer: slow but steady progress J Clin Oncol 21 2003 4259 4260 (Pubitemid 46621796)
25. L. Rath-Wolfson, B. Moskovitz, Y. Dekel, V. Kugel, and R. Koren Combined intravesical hyperthermia and mitomycin chemotherapy: a preliminary in vivo study Int J Exp Pathol 84 2003 145 152 (Pubitemid 37188257)
26. R. Colombo, A. Salonia, and L.F. Da Pozzo Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience Crit Rev Oncol Hematol 47 2003 127 139 (Pubitemid 36945311)
27. R. Colombo, M. Brausi, and L.F. Da Pozzo Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion Eur Urol 39 2001 95 100 (Pubitemid 32098477)
28. R. Colombo, L.F. Da Pozzo, and A. Lev Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors J Urol 159 1998 783 787 (Pubitemid 28106525)
29. R. Paroni, C. Arcelloni, E. De Vecchi, I. Fermo, D. Mauri, and R. Colombo Plasma mitomycin C concentrations determined by HPLC coupled to solid-phase extraction Clin Chem 43 1997 615 618
30. R. Colombo, L.F. Da Pozzo, A. Lev, M. Freschi, G. Gallus, and P. Rigatti Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer J Urol 155 1996 1227 1232 (Pubitemid 26081201)
31. E.D. Crawford Diagnosis and treatment of superficial bladder cancer: an update Semin Urol Oncol 14 1996 1 9 (Pubitemid 26117514)
32. R. Colombo, A. Lev, L.F. Da Pozzo, M. Freschi, G. Gallus, and P. Rigatti A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment J Urol 153 1995 959 963
33. T. Uchibayashi, K. Nakajima, H. Hisazumi, A. Nishino, and N. Miyoshi Hyperthermic intravesical peplomycin perfusion treatment for bladder cancer Br J Urol 72 1993 65 67 (Pubitemid 23227436)
34. C.N. Batts Adjuvant intravesical therapy for superficial bladder cancer Ann Pharmacother 26 1992 1270 1276
35. H. Matzkin, M.C. Rangel, and M.S. Soloway In vitro study of the effect of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell lines J Urol 147 1992 1671 1674
36. P. Rigatti, A. Lev, and R. Colombo Combined intravesical chemotherapy with mitomycin C and local bladder microwave-induced hyperthermia as a preoperative therapy for superficial bladder tumors. A preliminary clinical study Eur Urol 20 1991 204 210
37. R. Colombo, A. Salonia, Z. Leib, M. Pavone-Macaluso, and D. Engelstein Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC) BJU Int 107 2011 912 918
38. B.E. Ayres, A. Connor, C. Corbishley, and M.J. Bailey 3-year single-centre UK experience of radiofrequency hyperthermia and mitomycin C in BCG failures [abstract] BJU Int 106 Suppl s1 2010
39. B.P. Schrier, M.P. Hollander, B.W.G. van Rhijn, L.A.L.M. Kiemeney, and J.A. Witjes Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy Eur Urol 45 2004 292 296 (Pubitemid 38221401)
40. T.J. Guzzo, A. Magheli, and T.J. Bivalacqua Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer Urology 74 2009 1276 1280
41. M.D. Shelley, J.B. Court, H. Kynaston, T.J. Wilt, B. Coles, and M. Mason Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer Cochrane Database Syst Rev 2003 CD003231
42. A randomized controlled study comparing adjuvant hyperthermia treatment in conjunction with mitomycin C versus BCG immunotherapy (BCG) adjuvant treatment in patients with superficial transitional cell carcinoma of the bladder (STCCB) [identifier NCT00384891 ]. ClinicalTrials.gov Web site. http://www.clinicaltrials.gov/ct2/show/NCT00384891.
43. HYMN: a randomized controlled phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guerin or standard therapy in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance bacillus Calmette-Guerin therapy [identifier NCT01094964 ]. ClinicalTrials.gov Web site. http://www.clinicaltrials.gov/ct2/ show/NCT01094964.
44. Cancer Treatment Centers of America purchases BSD-2000 hyperthermia system from BSD Medical [press release]. Salt Lake City, UT: BSD Medical, 2010. http://www.bsdmedical.com/press-view.php?press-id=351.
45. Pilot study of external hyperthermia and intravesical mitomycin-C to treat recurrent bladder cancer after resection and standard adjuvant therapy [identifier NCT00734994 ]. ClinicalTrials.gov Web site. http://www. clinicaltrials.gov/ct2/show/NCT00734994.
46. R.J. Sylvester, W. Oosterlinck, and J.A. Witjes The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials Eur Urol 53 2008 709 719
47. K. Nakajima, and H. Hisazumi An experimental study of enhanced cell killing by hyperthermia and bleomycin Urol Res 11 1983 43 46 (Pubitemid 13093079)
48. C. Prinsze, L.C. Penning, T.M. Dubbelman, and J. VanSteveninck Interaction of photodynamic treatment and either hyperthermia or ionizing radiation and of ionizing radiation and hyperthermia with respect to cell killing of L929 fibroblasts, Chinese hamster ovary cells, and T24 human bladder carcinoma cells Cancer Res 52 1992 117 120